Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors.

Shimomura A, Yamamoto N, Kondo S, Fujiwara Y, Suzuki S, Yanagitani N, Horiike A, Kitazono S, Ohyanagi F, Doi T, Kuboki Y, Kawazoe A, Shitara K, Ohno I, Banerji U, Sundar R, Ohkubo S, Calleja EM, Nishio M.

Mol Cancer Ther. 2019 Mar;18(3):531-540. doi: 10.1158/1535-7163.MCT-18-0831. Epub 2019 Jan 24.

PMID:
30679388
2.

Irregular Liesegang-type patterns in gas phase revisited. I. Experimental setup, data processing, and test of the spacing law.

Torres-Guzmán JC, Buhse T, de la Calleja EM, González-Espinoza A, Martínez-Mekler G, Montoya-Nava F, Ramírez-Álvarez E, Rivera-Islas M, Rodríguez-Álvarez A, Müller MF.

J Chem Phys. 2016 May 7;144(17):174701. doi: 10.1063/1.4946791.

PMID:
27155641
3.

The k-space origins of scattering in Bi2Sr2CaCu2O8+x.

Alldredge JW, Calleja EM, Dai J, Eisaki H, Uchida S, McElroy K.

J Phys Condens Matter. 2013 Aug 21;25(33):335601. doi: 10.1088/0953-8984/25/33/335601. Epub 2013 Jul 25.

PMID:
23883664
4.
5.

Survival and morbidity in transfusion-dependent thalassemic patients on subcutaneous desferrioxamine chelation. Nearly two decades of experience.

Calleja EM, Shen JY, Lesser M, Grady RW, New MI, Giardina PJ.

Ann N Y Acad Sci. 1998 Jun 30;850:469-70. No abstract available.

PMID:
9668587

Supplemental Content

Loading ...
Support Center